Keenova Therapeutics Plc Revenue per Employee (MNK), current and historic results, rankings and more, quarterly fundamentals - CSIMarket
CSIMarket Company Name, Ticker, Customers, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
Keenova Therapeutics Plc  (MNK)
 

Keenova Therapeutics Plc's Revenue per Employee

Quarterly Results, Trends, Rankings, Statistics, Cumulative Sales


Keenova Therapeutics Plc's Revenue per employee fell on a trailing twelve month basis to $ 883,125, but the productivity of Keenova Therapeutics Plc's employees remained above the company average.
Within the Healthcare sector Employees of 112 other companies have achieved higher revenue per employee. While revenue/employee total ranking has improved so far to 1023, from total ranking in previous quarter at 1155. Keenova Therapeutics Plc has 1,600 employees.


What is Sales per Employee Ratio?






Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

MNK Revenue per Employee (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 26 2025)
III. Quarter		 (Mar 28 2025)
I. Quarter		 (Sep 27 2024)
III. Quarter
Y / Y Revenue Change -7.42 % - 61.24 % -48.36 % 1.67 %
Sales per Employee (TTM) $ 883,125 906,563 1,370,000 1,191,250 1,437,063
MNK's Total Ranking # 1023 # 1155 # 917 # 1010 #
Seq. Revenue Change - - 79.33 % -16.87 % -1.73 %

MNK Company Profile >> Back to MNK Efficiency Comparisons >> Compare MNK Sales per Employee to its Competitors

Revenue per Employee Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 74
Healthcare Sector # 113
Overall Market # 1023

Revenue per Employee Statistics
High Average Low
$ 851,593 $ 745,399 $ 181,741
(Sep 27 2024)   (Apr 01 2022)



Financial Statements
Keenova Therapeutics Plc's Revenue MRQ $ 468 Millions Visit MNK's Income Statement
Keenova Therapeutics Plc's Revenues TTM $ 1,413 Millions Visit MNK's aggregate revenue growth
What are MNK's Sales? Visit MNK's Sales by Segment




Other Ratios
Keenova Therapeutics Plc's Income per Employee
Employees in Major Pharmaceutical Preparations
Major Pharmaceutical Preparations Industry Revenue per Employee Trends and Statistics
Healthcare Sector Revenue per Employee Statistics
Revenue per Employee Trends for overall market
MNK's Revenue per Employee versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Revenue per Employee
Lowest Ranking Revenue per Employee
Revenue per Employee for MNK's Competitors
Revenue per Employee for MNK's Suppliers
Revenue per Employee for MNK's Customers

You may also want to know
MNK's Sales Growth Rates MNK's Pe Price to earnings ratio MNK's Receivables Turnover Ratio MNK's Stock Quote
MNK's Net Income Growth Rates MNK's Ps Price to Sales ratio MNK's Sales per Employee MNK's Asset Turnover Ratio
MNK's Net Margin MNK's Pb Price to Book ratio MNK's Financial Strength Ratios MNK's Dividend Payout Ratio
Date modified: 2026-08-29T17:14:29+00:00




Companies with similar Revenue per Employee for 12 months ending Mar 31 2026, within Healthcare Sector Revenue per Employee Revenue 12 months ending Mar 31 2026Number of Employees Mar 31 2026
Jazz Pharmaceuticals Plc  1,535,863.32 $ 4,438.645  Million 2,890 
Mirum Pharmaceuticals Inc   1,531,206.99 $ 569.609  Million 372 
Agenus Inc  1,529,209.88 $ 123.866  Million 81 
Progyny Inc   1,510,233.64 $ 1,292.760  Million 856 
Apellis Pharmaceuticals Inc   1,495,642.76 $ 1,105.280  Million 739 
Bristol myers Squibb Company  1,491,753.85 $ 48,482.000  Million 32,500 
Fennec Pharmaceuticals Inc   1,457,114.29 $ 50.999  Million 35 
Eli Lilly And Company  1,444,990.00 $ 72,249.500  Million 50,000 
Esperion Therapeutics Inc   1,422,598.64 $ 418.244  Million 294 
Krystal Biotech Inc   1,414,589.83 $ 417.304  Million 295 
Acadia Pharmaceuticals Inc   1,372,493.73 $ 1,095.250  Million 798 
Liquidia Corporation  1,333,634.26 $ 288.065  Million 216 
Biogen Inc   1,324,986.67 $ 9,937.400  Million 7,500 
Lantheus Holdings Inc   1,295,200.34 $ 1,545.174  Million 1,193 
Indivior Pharmaceuticals Inc   1,292,000.00 $ 1,292.000  Million 1,000 
Puma Biotechnology Inc   1,269,150.84 $ 227.178  Million 179 
Madrigal Pharmaceuticals Inc   1,237,693.99 $ 1,132.490  Million 915 
Theravance Biopharma inc   1,219,722.22 $ 109.775  Million 90 
Akebia Therapeutics Inc   1,197,958.76 $ 232.404  Million 194 
Supernus Pharmaceuticals inc   1,191,461.66 $ 776.833  Million 652 
Arcutis Biotherapeutics Inc   1,174,079.10 $ 415.624  Million 354 
Heron Therapeutics Inc   1,173,312.50 $ 150.184  Million 128 
Cue Biopharma Inc   1,128,655.17 $ 32.731  Million 29 
Journey Medical Corp  1,115,172.41 $ 64.680  Million 58 
Abbvie Inc   1,102,087.72 $ 62,819.000  Million 57,000 
Travere Therapeutics Inc   1,078,863.18 $ 536.195  Million 497 
Corcept Therapeutics Inc  1,053,556.16 $ 769.096  Million 730 
Biomarin Pharmaceutical Inc  1,006,617.82 $ 3,242.316  Million 3,221 
Scilex Holding Company  995,941.18 $ 33.862  Million 34 
Coya Therapeutics Inc   992,377.00 $ 7.939  Million 8 




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.